Pancreatic cancer, a highly aggressive disease often detected late due to its subtle presentation, relies heavily on tumor markers to guide disease detection, treatment planning, and progression tracking.
Advanced cancer refers to the late stages of malignancies where cancer cells have spread beyond their origin, affecting vital organs and often becoming incurable.
Stage 4 pancreatic cancer occurs when pancreatic cancer spreads beyond the pancreas to distant organs, affecting approximately 50-60% of patients at diagnosis.
Colorectal cancer, encompassing cancers of the colon and rectum, is a prevalent malignancy with a high propensity for liver metastasis, affecting up to 50% of patients.
Germany stands as a global leader in advanced oncology, offering profound expertise in liver cancer monitoring through the strategic use of alpha-fetoprotein (AFP)
Germany is a global frontrunner in advanced oncology, pioneering the use of proton therapy as a revolutionary approach to liver cancer treatment.
According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide.
German clinics report an improvement of 5-year survival rates by up to 38-52% with advanced intraperitoneal chemotherapy methods and immune-based treatments, significantly outperforming conventional approaches used globally.
Pancreatic cancer affects your pancreas, a gland in your abdomen that aids in digestion. Pancreatic cancer symptoms include nausea, bloating, fatigue, jaundice and lack of appetite.
Germany is a global pioneer in advanced oncology, driving transformative therapeutic innovations for gastrointestinal neuroendocrine tumors (GI NETs). In 2025,
Liver cancer is a significant global health challenge, ranking among the top causes of cancer-related deaths worldwide.
As global leaders in oncology research and treatment, German hospitals combine cutting-edge technologies with comprehensive patient care.
Bladder cancer stage 4 is the most advanced form of the disease, characterized by the spread of cancer cells beyond the bladder to distant lymph nodes, the liver and lungs, and even the bones.
Pancreatic cancer is an aggressive tumor of the digestive system. One of the reasons for the low effectiveness of treatment for pancreatic tumors is the weak anti-tumor immune response.
